OV ... I concur, but do agree with one aspect that is critical of management. The company's PR and marketing has been woeful ... they have an awesome story to tell here and yet they seem to set the volume at 'yawn' at every turn. There is an art to writing an ASX media release that is readable and punchy but still contains science - their people do not know how. Happy to help them for $300 an hour. They'd owe me $150. It's not that hard.
Ann: Encouraging Early Data-Cynata Clinical Trial Proceeds, page-24
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.74M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 22.0¢ | $29.06K | 131.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 951 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.59pm 08/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |